APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

被引:12
|
作者
Singh, Neha Atulkumar [1 ]
Tosakulwong, Nirubol [2 ]
Graff-Radford, Jonathan [1 ]
Machulda, Mary M. [3 ]
Nha Trang Thu Pham [4 ]
Sintini, Irene [4 ]
Weigand, Stephen D. [2 ]
Schwarz, Christopher G. [4 ]
Senjem, Matthew L. [4 ]
Carrasquillo, Minerva M. [5 ]
Ertekin-Taner, Nilufer [5 ]
Jack, Clifford R., Jr. [4 ]
Lowe, Val J. [4 ]
Josephs, Keith A. [1 ]
Whitwell, Jennifer L. [4 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Radiol, 200 1st St SW, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Neurosci, Jacksonville, FL USA
基金
美国国家卫生研究院;
关键词
apolipoprotein epsilon 4; atypical Alzheimer's disease; logopenic progressive aphasia; posterior cortical atrophy; magnetic resonance imaging; tau positron emission tomography; POSTERIOR CORTICAL ATROPHY; CLINICAL PHENOTYPE; VARIANTS; ONSET; ASSOCIATION; AGE;
D O I
10.1002/alz.12711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Apolipoprotein E (APOE) epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), influencing brain volume and tau burden. Little is known about its influence in atypical presentations of AD. Methods: An atypical AD cohort of 140 patients diagnosed with either posterior cortical atrophy or logopenic progressive aphasia underwent magnetic resonance imaging and positron emission tomography. Linear mixed effects models were fit to assess the influence of APOE epsilon 4 on cross-sectional and longitudinal regional metrics. Results: At baseline, APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau standardized uptake volume ratio in the hippocampus and entorhinal cortex compared to non-carriers while longitudinally, APOE epsilon 4 non-carriers showed faster rates of atrophy and tau accumulation in the entorhinal cortex, with faster tau accumulation in the hippocampus. Discussion: APOE epsilon 4 influences patterns of neurodegeneration and tau deposition and was associated with more medial temporal involvement, although there is evidence that non-carriers may be catching up over time.
引用
收藏
页码:784 / 796
页数:13
相关论文
共 50 条
  • [41] APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Md. Sahab Uddin
    Md. Tanvir Kabir
    Abdullah Al Mamun
    Mohamed M. Abdel-Daim
    George E. Barreto
    Ghulam Md Ashraf
    Molecular Neurobiology, 2019, 56 : 2450 - 2465
  • [42] APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis
    Uddin, Md. Sahab
    Kabir, Md. Tanvir
    Al Mamun, Abdullah
    Abdel-Daim, Mohamed M.
    Barreto, George E.
    Ashraf, Ghulam Md
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2450 - 2465
  • [43] Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
    Sintini, Irene
    Martin, Peter R.
    Graff-Radford, Jonathan
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Machulda, Mary M.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Knopman, David S.
    Petersen, Ronald C.
    Lowe, Val J.
    Jack, Clifford R., Jr.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    NEUROIMAGE-CLINICAL, 2019, 23
  • [44] Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
    Phillips, Jeffrey S.
    Das, Sandhitsu R.
    McMillan, Corey T.
    Irwin, David J.
    Roll, Emily E.
    Da Re, Fulvio
    Nasrallah, Ilya M.
    Wolk, David A.
    Grossman, Murray
    HUMAN BRAIN MAPPING, 2018, 39 (02) : 691 - 708
  • [45] ApoE4: A RISK FACTOR FOR ALZHEIMER'S DISEASE
    Agarwala, A.
    Durakoglugil, M.
    Xian, D.
    Bowen, I
    Herz, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 469 - 469
  • [46] APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians
    Gureje, O
    Ogunniyi, A
    Baiyewu, O
    Price, B
    Unverzagt, FW
    Evans, RM
    Smith-Gamble, V
    Lane, KA
    Gao, SJ
    Hall, KS
    Hendrie, HC
    Murrell, JR
    ANNALS OF NEUROLOGY, 2006, 59 (01) : 182 - 185
  • [47] Epigenetic Downregulation of ApoE4 for Alzheimer's Disease
    Asmus, Natalie
    Moncalvo, Malik
    Dong, Wendy
    Ilich, Ekaterina
    Falek, Carmel
    Rittiner, Joseph
    Tringali, Domenic
    Yun, Young
    Gu, Jeffrey
    Wei, Angela
    Yang, Anna
    Angrist, Misha
    Chiba-Falek, Ornit
    Kantor, Boris
    MOLECULAR THERAPY, 2020, 28 (04) : 430 - 430
  • [48] Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study
    Mattsson, Niklas
    Ossenkoppele, Rik
    Smith, Ruben
    Strandberg, Olof
    Ohlsson, Tomas
    Jogi, Jonas
    Palmqvist, Sebastian
    Stomrud, Erik
    Hansson, Oskar
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [49] ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease
    Kang, Seong Su
    Ahn, Eun Hee
    Liu, Xia
    Bryson, Matthew
    Miller, Gary W.
    Weinshenker, David
    Ye, Keqiang
    ACTA NEUROPATHOLOGICA, 2021, 142 (01) : 139 - 158
  • [50] Astrocytic tau deposition is frequent in Alzheimer disease
    Nolan, Amber
    De Paula, Elisa
    Resende, Franca
    Petersen, Cathrine
    Ehrenberg, Alexander
    Spina, Salvatore
    Miller, Bruce
    Seeley, William
    Grinberg, Lea
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 504 - 504